Abstract
Metabolic disturbances in chronic kidney disease and failure include not only retention, but also deficiency and namely complex regulatory derangement. Clinical consequences of retention of advanced glycation products, leptin, beta-2-microglobulin and other substances are mentioned together with the current classification of so far known approx. 90 substances retained in renal failure.